A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate

Clinical trial NCT00298987 · COMPLETED

Trial details

NCT number: NCT00298987
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic Leukemia, Lymphocytic, Acute, L2

Start date: 2006-02-01
Primary completion: 2007-06-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.